Dr John E Emmons, DO in Wentzville, MO - Medicare Family Practice

Dr John E Emmons, DO is a medicare enrolled "Family Medicine" physician in Wentzville, Missouri. He went to At Still University Of Health Sciences, College Of Osteo Med, Kirksville and graduated in 1979 and has 45 years of diverse experience with area of expertise as Family Practice. He is a member of the group practice Fast Track Medical Llc and his current practice location is 1032 Crosswinds Ct, Wentzville, Missouri. You can reach out to his office (for appointments etc.) via phone at (636) 332-6000.

Dr John E Emmons is licensed to practice in Missouri (license number R7A71) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1437275948.

Contact Information

	Dr John E Emmons, DO
	1032 Crosswinds Ct, Wentzville, MO 63385-4836
	(636) 332-6000
	Not Available

Physician's Profile

Full Name	Dr John E Emmons
Gender	Male
Speciality	Family Practice
Experience	45 Years
Location	1032 Crosswinds Ct, Wentzville, Missouri
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr John E Emmons attended and graduated from At Still University Of Health Sciences, College Of Osteo Med, Kirksville in 1979

NPI Data:

NPI Number: 1437275948
Provider Enumeration Date: 03/22/2007
Last Update Date: 04/30/2018

Medicare PECOS Information:

PECOS PAC ID: 7517939010
Enrollment ID: I20040806000111

Medical Identifiers

Medical identifiers for Dr John E Emmons such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1437275948	NPI	-	NPPES
A10551	Other		UHC
4574194	Other		ATN
1437275948	Medicaid	MO
9202	Other	MO	BCBS

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Q00000X	Family Medicine	R7A71 (Missouri)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Fast Track Medical Llc	2062693336	11

News Archive

FDA approves Ryanodex for treatment of malignant hyperthermia linked with anesthesia

Eagle Pharmaceuticals, Inc. today announced the U. S. Food and Drug Administration (FDA) has approved Ryanodex® (dantrolene sodium) for injectable suspension indicated for the treatment of malignant hyperthermia (MH), along with the appropriate supportive measures.

Pelosi on health reform: 'We will make every effort'

The Washington Post / Reuters: House Speaker Nancy Pelosi, D-Calif., said today that abandoning health care reform was not a possibility. "'Let's put it this way. The present (healthcare) system is unsustainable. We can no longer afford it ... We will make every effort to have a health care bill. But we will make progress, whatever it is, one way or the other, we will go forward with that'" (Maler, 1/27).

GEN co-sponsored roundtable discussion on Gulf Oil Spill

Genetic Engineering & Biotechnology News announced that on Thursday, October 28th, they co-sponsored a roundtable discussion on new ways to use biological solutions to assist in environment cleanup after manmade or natural disasters.

Allergan announces U.S. availability of SAPHRIS 2.5 mg tablets for children with bipolar I disorder

Allergan plc today announced that SAPHRIS (asenapine) 2.5 mg sublingual (placed under the tongue) black-cherry flavored tablets are available in pharmacies throughout the U.S. In March 2015, the U.S. Food and Drug Administration approved SAPHRIS for the acute treatment of manic or mixed episodes associated with bipolar I disorder in pediatric patients (ages 10 – 17).

FDA grants Fast Track Designation to TxCell's Ovasave for treatment of Crohn's disease

TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that the United States Food and Drug Administration has granted Fast Track Designation to TxCell's lead product Ovasave for the treatment of moderate to severe Crohn's disease.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr John E Emmons allows following entities to bill medicare on his behalf.

Entity Name	Great Mines Health Center
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1376536953 PECOS PAC ID: 3072598143 Enrollment ID: O20041004000035

News Archive

FDA approves Ryanodex for treatment of malignant hyperthermia linked with anesthesia

Pelosi on health reform: 'We will make every effort'

GEN co-sponsored roundtable discussion on Gulf Oil Spill

Allergan announces U.S. availability of SAPHRIS 2.5 mg tablets for children with bipolar I disorder

FDA grants Fast Track Designation to TxCell's Ovasave for treatment of Crohn's disease

Entity Name	Fast Track Medical Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1568770626 PECOS PAC ID: 2062693336 Enrollment ID: O20110218000623

FDA approves Ryanodex for treatment of malignant hyperthermia linked with anesthesia

Pelosi on health reform: 'We will make every effort'

GEN co-sponsored roundtable discussion on Gulf Oil Spill

Allergan announces U.S. availability of SAPHRIS 2.5 mg tablets for children with bipolar I disorder

FDA grants Fast Track Designation to TxCell's Ovasave for treatment of Crohn's disease

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr John E Emmons is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr John E Emmons, DO 1800 Community, Clinton, MO 64735-8804 Ph: (660) 885-8131	Dr John E Emmons, DO 1032 Crosswinds Ct, Wentzville, MO 63385-4836 Ph: (636) 332-6000

News Archive

FDA approves Ryanodex for treatment of malignant hyperthermia linked with anesthesia

Pelosi on health reform: 'We will make every effort'

GEN co-sponsored roundtable discussion on Gulf Oil Spill

Allergan announces U.S. availability of SAPHRIS 2.5 mg tablets for children with bipolar I disorder

FDA grants Fast Track Designation to TxCell's Ovasave for treatment of Crohn's disease

Family Medicine Doctors in Wentzville, MO

Dr. Chad Ryan Fowler, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1032 Crosswinds Ct, Wentzville, MO 63385 Phone: 844-853-8937
Julia Ellen Garza, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1502 W Meyer Rd, Wentzville, MO 63385 Phone: 636-698-6266
David Fouts, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 500 Medical Dr, Wentzville, MO 63385 Phone: 800-968-6866
Dr. Natalie Nicole Nekouian, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1598 W Meyer Rd, Wentzville, MO 63385 Phone: 636-332-8228 Fax: 636-332-1190
Sandhya Vallem, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1032 Crosswinds Ct, Wentzville, MO 63385 Phone: 844-853-8937
Sarah Emily Whittaker, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1598 W Meyer Rd, Wentzville, MO 63385 Phone: 636-332-8228
Dr. John C Wendt, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1520 Wentzville Pkwy, Wentzville, MO 63385 Phone: 636-497-4000

Dr John E Emmons, DO - Medicare Family Practice in Wentzville, MO

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

FDA approves Ryanodex for treatment of malignant hyperthermia linked with anesthesia

Pelosi on health reform: 'We will make every effort'

GEN co-sponsored roundtable discussion on Gulf Oil Spill

Allergan announces U.S. availability of SAPHRIS 2.5 mg tablets for children with bipolar I disorder

FDA grants Fast Track Designation to TxCell's Ovasave for treatment of Crohn's disease

Medicare Reassignments

FDA approves Ryanodex for treatment of malignant hyperthermia linked with anesthesia

Pelosi on health reform: 'We will make every effort'

GEN co-sponsored roundtable discussion on Gulf Oil Spill

Allergan announces U.S. availability of SAPHRIS 2.5 mg tablets for children with bipolar I disorder

FDA grants Fast Track Designation to TxCell's Ovasave for treatment of Crohn's disease

FDA approves Ryanodex for treatment of malignant hyperthermia linked with anesthesia

Pelosi on health reform: 'We will make every effort'

GEN co-sponsored roundtable discussion on Gulf Oil Spill

Allergan announces U.S. availability of SAPHRIS 2.5 mg tablets for children with bipolar I disorder

FDA grants Fast Track Designation to TxCell's Ovasave for treatment of Crohn's disease

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

FDA approves Ryanodex for treatment of malignant hyperthermia linked with anesthesia

Pelosi on health reform: 'We will make every effort'

GEN co-sponsored roundtable discussion on Gulf Oil Spill

Allergan announces U.S. availability of SAPHRIS 2.5 mg tablets for children with bipolar I disorder

FDA grants Fast Track Designation to TxCell's Ovasave for treatment of Crohn's disease

Family Medicine Doctors in Wentzville, MO